Galectin Therapeutics Inc (NASDAQ:GALT) does about 260.11K shares in volume on a normal day but saw 918761 shares change hands in the recent trading day. The company now has a market cap of 132.09M USD. Its current market price is $2.12, marking a decrease of -8.23% compared to the previous close of $2.31. The 52 week high reached by this stock is $4.27 whilst the lowest price level in 52 weeks is $1.55.
Galectin Therapeutics Inc (GALT) has a 20-day trading average at $2.42 and the current price is -50.33% off the 52-week high compared with 36.33% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.57 and its 200-day simple moving average is $2.65. If we look at the stock’s price movements over the week, volatility stands at 10.80%, which decreases to 9.09% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 39.84 to suggest the stock is neutral.
The consensus objective for the share price is $11.00, suggesting that the stock has a potential upside of 80.73% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 13, 2020 when H.C. Wainwright reiterated the stock to “Buy” and issued a price target of between $9 and $12. H.C. Wainwright reiterated its price target at $6-$10.
The current price level is -12.57%, -17.50%, and -19.96% away from its SMA20, SMA50, and SMA200 respectively, with the GALT price moving above the 50-day SMA on current market day. Galectin Therapeutics Inc (GALT) stock is up 9.84% over the week and -23.47% over the past month. Its price is 27.71% year-to-date and 32.50% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 80.73 percent from here.
The company has a return on investment of -2675.95%. The beta has a value of 0.71.
